IGC Pharma (IGC) Payables (2011 - 2026)
IGC Pharma (IGC) reported Payables of $1.3 million for Q1 2026, up 42.13% year-over-year from $883000.0 in Q1 2025, and up 23.77% quarter-over-quarter from $1.0 million in Q4 2025.
IGC Pharma (IGC) Payables (2011 - 2026) Analysis & Trends
IGC Pharma (IGC) has 16 years of Payables data on file, last reported at $1.3 million in Q1 2026.
- Payables for Q1 2026 came in at $1.3 million, up 42.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (up 42.13% YoY), and the FY2026 annual result was $1.3 million, up 42.13% from the prior year.
- Payables grew to $1.3 million in Q1 2026 per IGC's latest filing, from $1.0 million in the prior quarter.
- Over five years, Payables peaked at $1.6 million in Q3 2023 and troughed at $456000.0 in Q3 2022.
- A 5-year average of $845647.1 and a median of $773000.0 in 2024 frame the typical range for Payables.
- The sharpest annual moves came in 2022 and 2023: Payables sank 71.45% in 2022, then jumped 241.45% in 2023.
- A 5-year view of Payables shows it stood at $466000.0 in 2022, then soared by 39.06% to $648000.0 in 2023, then rose by 28.86% to $835000.0 in 2024, then advanced by 21.44% to $1.0 million in 2025, then climbed by 23.77% to $1.3 million in 2026.
- Business Quant data shows IGC's Payables at $1.3 million in Q1 2026, $1.0 million in Q4 2025, and $628000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 8.69 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 34.55 Mn |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - | 1.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.26 Mn |
| Dec 31, 2025 | 1.01 Mn |
| Sep 30, 2025 | 628,000.00 |
| Jun 30, 2025 | 933,000.00 |
| Mar 31, 2025 | 883,000.00 |
| Dec 31, 2024 | 835,000.00 |
| Sep 30, 2024 | 768,000.00 |
| Jun 30, 2024 | 771,000.00 |
| Mar 31, 2024 | 773,000.00 |
| Dec 31, 2023 | 648,000.00 |
| Sep 30, 2023 | 1.56 Mn |
| Jun 30, 2023 | 672,000.00 |
| Mar 31, 2023 | 530,000.00 |
| Dec 31, 2022 | 466,000.00 |
| Sep 30, 2022 | 456,000.00 |
| Jun 30, 2022 | 1.20 Mn |
| Mar 31, 2022 | 984,000.00 |
| Dec 31, 2021 | 360,000.00 |
| Sep 30, 2021 | 1.60 Mn |
| Jun 30, 2021 | 1.55 Mn |